US OptionsDetailed Quotes
VKTX241129C58000
- 0.09
- -0.11-55.00%
15min DelayClose Nov 27 16:00 ET
0.15High0.05Low
0.12Open0.20Pre Close34 Volume399 Open Interest58.00Strike Price333.00Turnover92.30%IV6.57%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.09Extrinsic Value100Contract SizeAmericanOptions Type0.1617Delta0.0739Gamma198.22Leverage Ratio-0.2353Theta0.0004Rho32.05Eff Leverage0.0088Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet